We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Surprising Cause Found of Spinal Cord Injury

By Biotechdaily staff writers
Posted on 06 Aug 2004
An energy source that normally keeps the body's cells alive has been found to spread out of control at the site of spinal cord injury, pouring into the area around the wound and killing the cells that normally allow movement.

The fact that high levels of this energy source, ATP (adenosine triphosphate), have been found to also kill healthy cells in nearby regions of the spinal cord that were not injured is also surprising. More...
It is the first time that high levels of ATP have been identified as a cause of bodily injury. The findings were reported in the August issue of Nature Medicine.

Researchers from the University of Rochester Medical Center (NY, USA; www.rochester.edu) found that excess ATP damages motor neurons, whose death in the spinal cord results in paralysis. When the researchers blocked ATP's effects on neurons, the rats with damaged spinal cords recovered most of their function, walking and climbing nearly as well as healthy rats. This finding offers promise mainly to people who have just had a spinal cord injury, but not for those whose injury is more than a day old.

"This is an unusual way of looking at spinal cord injury,” explained Maiken Nedergaard, M.D., Ph.D., a professor of neurosurgery at the University of Rochester, who led the study. "Much of the focus of research has been on trying to regrow portions of the spinal cord. We're trying to stop the damage up front.”

The researchers used the same technology that underlies the enzyme luciferase to convert ATP to the glow it uses to light up. Dr. Nedergaard's team used the same enzyme to study the levels of ATP around the site of spinal cord injury, recording a very bright signal there for several hours. Although low levels of ATP provide a quick way for cells to communicate, Dr. Nedergaard said that levels found in the spinal cord were hundreds of times more higher than normal. The glut of ATP overstimulates neurons and causes them to die from metabolic stress.

The reason why neurons in the spinal cord are so susceptible to ATP is because of a molecule known as "the death receptor.” Also called P2X7, this receptor plays a role in regulating the deaths of immune cells such as macrophages. ATP uses this receptor to latch onto neurons and send them the flood of signals that causes their deaths. Dr. Nedergaard's team discovered that P2X7 is carried in abundance by neurons in the spinal cord.

The source of the ATP that kills the neurons gave researchers another surprise. Star-shaped cells called astrocytes, long thought to be simply passive support cells for neurons in the nervous system, produce the high levels of ATP. Scientists are beginning to believe that astrocytes also play a vital role in human health by nourishing neurons, supplying them with chemicals they need, and vacuuming up excess chemicals in order to keep the signals of neurons crisp.

"For a long time, astrocytes were thought of simply as the housekeepers of the brain, feeding the neurons and regulating their environment,” said Dr. Nedergaard. "But astrocytes are much more active than we have thought. It appears that sometimes astrocytes even give out the instructions telling neurons what to do. It's very likely they play an important role in many human diseases.”



Related Links:
U. of Rochester

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.